![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Investigational Studies to Understand the Decreases in Lymphocytes Seen Clinically with Islatravir (ISL) and Enabling 1the Initiation of New Clinical Trials
|
|
|
Jose A. Lebron , Zhanna Sobol , John Barnum , Tracy L. Diamond , Daphne Ma , Bhavana Bhatt , Nianyu Li , Zhibin Wang , Bang-Lin Wan , Fangbiao Li , Midhun Korrapati , Yuan Li1, Qian Huang1, Kerry L.
Fillgrov e1, Qiuwei Xu1, Amy G. Aslamkhan1, Liping Liu1, Morgan Monslow1, Ryan Staupe1, Jia Yao Phuah1, Nithya Thambi1, Kalpit A. Vora1, Ryan Vargo1, Ernest Asante-Appiah1, and Sandrine Ferry-Martin2
1Merck & Co., Inc., Rahway, NJ, USA; 2MSD, France.
![1023231](../images/102323/102323-14/1023231.gif)
![1023232](../images/102323/102323-14/1023232.gif)
![1023233](../images/102323/102323-14/1023233.gif)
![1023234](../images/102323/102323-14/1023234.gif)
![1023235](../images/102323/102323-14/1023235.gif)
![1023236](../images/102323/102323-14/1023236.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|